-
Use of bremsstrahlung radiation to identify hidden weak beta- sources: feasibility and possible use in radio-guided surgery
Authors:
D. Carlotti,
F. Collamatii,
R. Faccinii,
P. Freschi,
F. Iacoangelii,
Mancini-Terraccianoi,
M. Marafinii,
R. Mirabellii,
L. Recchiai,
A. Russomandoi,
E. Solfaroli Camillocci i,
M. Toppii,
G. Trainii,
V. Bocci
Abstract:
The recent interest in beta- radionuclides for radio-guided surgery derives from the feature of the beta radiation to release energy in few millimeters of tissue. Such feature can be used to locate residual tumors with a probe located in its immediate vicinity, determining the resection margins with an accuracy of millimeters. The drawback of this technique is that it does not allow to identify tu…
▽ More
The recent interest in beta- radionuclides for radio-guided surgery derives from the feature of the beta radiation to release energy in few millimeters of tissue. Such feature can be used to locate residual tumors with a probe located in its immediate vicinity, determining the resection margins with an accuracy of millimeters. The drawback of this technique is that it does not allow to identify tumors hidden in more than few mm of tissue. Conversely, the bremsstrahlung X-rays emitted by the interaction of the beta- radiation with the nuclei of the tissue are relatively penetrating. To complement the beta- probes, we have therefore developed a detector based on cadmium telluride, an X-ray detector with a high quantum efficiency working at room temperature. We measured the secondary emission of bremsstrahlung photons in a target of Polymethylmethacrylate (PMMA) with a density similar to living tissue. The results show that this device allows to detect a 1 ml residual or lymph-node with an activity of 1 kBq hidden under a layer of 10 mm of PMMA with a 3:1 signal to noise, i.e. with a five sigma discrimination in less than 5 s.
△ Less
Submitted 24 October, 2017;
originally announced October 2017.
-
Feasibility of the $β^-$ Radio-Guided Surgery with a Variety of Radio-Nuclides of Interest to Nuclear Medicine
Authors:
Carlo Mancini-Terracciano,
Raffaella Donnarumma,
Gaia Bencivenga,
Valerio Bocci,
Antonella Cartoni,
Francesco Collamati,
Ilaria Fratoddi,
Alessandro Giordano,
Luca Indovina,
Michela Marafini,
Silvio Morganti,
Dante Rotili,
Andrea Russomando,
Teresa Scotognella,
Elena Solfaroli Camillocci,
Marco Toppi,
Giacomo Traini,
Iole Venditti,
Riccardo Faccini
Abstract:
The $β^-$ based radio-guided surgery overcomes the corresponding $γ$ technique in case the background from healthy tissues is relevant. It can be used only in case a radio-tracer marked with $^{90}$Y is available since the current probe prototype was optimized for the emission spectrum of this radio-nuclide. Here we study, with a set of laboratory tests and simulations, the prototype capability in…
▽ More
The $β^-$ based radio-guided surgery overcomes the corresponding $γ$ technique in case the background from healthy tissues is relevant. It can be used only in case a radio-tracer marked with $^{90}$Y is available since the current probe prototype was optimized for the emission spectrum of this radio-nuclide. Here we study, with a set of laboratory tests and simulations, the prototype capability in case a different radio-nuclide is chosen among those used in nuclear medicine.
As a result we estimate the probe efficiency on electrons and photons as a function of energy and we evaluate the feasibility of a radio-guided surgery exploiting the selected radio-nuclides. We conclude that requiring a 0.1~ml residue to be detected within 1~s by administering 3~MBq/Kg of radio-isotope, the current probe prototype would yield a significant signal in a vast range of values of SUV and TNR in case $^{31}$Si,$^{32}$P, $^{97}$Zr, and $^{188}$Re are used. Conversely, a tuning of the detector would be needed to efficiency use $^{83}$Br, $^{133}$I, and $^{153}$Sm, although they could already be used in case of high SUV or TNR values. Finally, $^{18}$F,$^{67}$Cu, $^{131}$I, and $^{177}$Lu are not useable for radio-guided surgery with the current probe design.
△ Less
Submitted 28 October, 2016;
originally announced October 2016.
-
First Ex-Vivo Validation of a Radioguided Surgery Technique with beta- Radiation
Authors:
E. Solfaroli Camillocci,
M. Schiariti,
V. Bocci,
A. Carollo,
G. Chiodi,
M. Colandrea,
F. Collamati,
M. Cremonesi,
R. Donnarumma,
M. E. Ferrari,
P. Ferroli,
F. Ghielmetti,
C. M. Grana,
M. Marafini,
S. Morganti,
C. Mancini Terracciano,
M. Patanè,
G. Pedroli,
B. Pollo,
L. Recchia,
A. Russomando,
M. Toppi,
G. Traini,
R. Faccini
Abstract:
Purpose: A radio-guided surgery technique with beta- -emitting radio-tracers was suggested to overcome the effect of the large penetration of gamma radiation. The feasibility studies in the case of brain tumors and abdominal neuro-endocrine tumors were based on simulations starting from PET images with several underlying assumptions. This paper reports, as proof-of-principle of this technique, an…
▽ More
Purpose: A radio-guided surgery technique with beta- -emitting radio-tracers was suggested to overcome the effect of the large penetration of gamma radiation. The feasibility studies in the case of brain tumors and abdominal neuro-endocrine tumors were based on simulations starting from PET images with several underlying assumptions. This paper reports, as proof-of-principle of this technique, an ex-vivo test on a meningioma patient. This test allowed to validate the whole chain, from the evaluation of the SUV of the tumor, to the assumptions on the bio-distribution and the signal detection.
Methods: A patient affected by meningioma was administered 300 MBq of 90Y-DOTATOC. Several samples extracted from the meningioma and the nearby Dura Mater were analyzed with a beta- probe designed specifically for this radio-guided surgery technique. The observed signals were compared both with the evaluation from the histology and with the Monte Carlo simulation.
Results: we obtained a large signal on the bulk tumor (105 cps) and a significant signal on residuals of $\sim$0.2 ml (28 cps). We also show that simulations predict correctly the observed yields and this allows us to estimate that the healthy tissues would return negligible signals (~1 cps). This test also demonstrated that the exposure of the medical staff is negligible and that among the biological wastes only urine has a significant activity.
Conclusions: This proof-of-principle test on a patient assessed that the technique is feasible with negligible background to medical personnel and confirmed that the expectations obtained with Monte Carlo simulations starting from diagnostic PET images are correct.
△ Less
Submitted 30 August, 2016;
originally announced August 2016.
-
Secondary radiation measurements for particle therapy applications: nuclear fragmentation produced by $^4$He ion beams in a PMMA target
Authors:
M. Marafini,
R. Paramatti,
D. Pinci,
G. Battistoni,
F. Collamati,
E. De Lucia,
R. Faccini,
P. M. Frallicciardi,
C. Mancini-Terracciano,
I. Mattei,
S. Muraro,
L. Piersanti,
M. Rovituso,
A. Rucinski,
A. Russomando,
A. Sarti,
A. Sciubba,
E. Solfaroli Camillocci,
M. Toppi,
G. Traini,
C. Voena,
V. Patera
Abstract:
Nowadays there is a growing interest in Particle Therapy treatments exploiting light ion beams against tumors due to their enhanced Relative Biological Effectiveness and high space selectivity. In particular promising results are obtained by the use of $^4$He projectiles. Unlike the treatments performed using protons, the beam ions can undergo a fragmentation process when interacting with the atom…
▽ More
Nowadays there is a growing interest in Particle Therapy treatments exploiting light ion beams against tumors due to their enhanced Relative Biological Effectiveness and high space selectivity. In particular promising results are obtained by the use of $^4$He projectiles. Unlike the treatments performed using protons, the beam ions can undergo a fragmentation process when interacting with the atomic nuclei in the patient body. In this paper the results of measurements performed at the Heidelberg Ion-Beam Therapy center are reported. For the first time the absolute fluxes and the energy spectra of the fragments - protons, deuterons, and tritons - produced by $^4$He ion beams of 102, 125 and 145 MeV/u energies on a poly-methyl methacrylate target were evaluated at different angles. The obtained results are particularly relevant in view of the necessary optimization and review of the Treatment Planning Software being developed for clinical use of $^4$He beams in clinical routine and the relative benchmarking of Monte Carlo algorithm predictions.
△ Less
Submitted 29 August, 2016;
originally announced August 2016.
-
Secondary radiation measurements for particle therapy applications: Charged secondaries produced by 4He and 12C ion beams in a PMMA target at large angle
Authors:
A. Rucinski,
E. De Lucia,
G. Battistoni,
F. Collamati,
R. Faccini,
P. M. Frallicciardi,
C. Mancini-Terracciano,
M. Marafini,
I. Mattei,
S. Muraro,
R. Paramatti,
L. Piersanti,
D. Pinci,
A. Russomando,
A. Sarti,
A. Sciubba,
E. Solfaroli Camillocci,
M. Toppi,
G. Traini,
C. Voena,
V. Patera
Abstract:
Measurements performed with the purpose of characterizing the charged secondary radiation for dose release monitoring in particle therapy are reported. Charged secondary yields, energy spectra and emission profiles produced in poly-methyl methacrylate (PMMA) target by 4He and 12C beams of different therapeutic energies were measured at 60 and 90 degree with respect to the primary beam direction. T…
▽ More
Measurements performed with the purpose of characterizing the charged secondary radiation for dose release monitoring in particle therapy are reported. Charged secondary yields, energy spectra and emission profiles produced in poly-methyl methacrylate (PMMA) target by 4He and 12C beams of different therapeutic energies were measured at 60 and 90 degree with respect to the primary beam direction. The secondary yields of protons produced along the primary beam path in PMMA target were obtained. The energy spectra of charged secondaries were obtained from time-of-flight information, whereas the emission profiles were reconstructed exploiting tracking detector information. The measured charged secondary yields and emission profiles are in agreement with the results reported in literature and confirm the feasibility of ion beam therapy range monitoring using 12C ion beam. The feasibility of range monitoring using charged secondary particles is also suggested for 4He ion beam.
△ Less
Submitted 16 August, 2016;
originally announced August 2016.
-
Secondary radiation measurements for particle therapy applications: prompt photons produced by $^{4}$He, $^{12}$C and $^{16}$O ion beams in a PMMA target
Authors:
Ilaria Mattei,
Francesco Collamati,
Erika De Lucia,
Riccardo Faccini,
Paola Maria Frallicciardi,
Carlo Mancini-Terracciano,
Michela Marafini,
Silvia Muraro,
Riccardo Paramatti,
Vincenzo Patera,
Luca Piersanti,
Davide Pinci,
Antoni Rucinski,
Andrea Russomando,
Alessio Sarti,
Adalberto Sciubba,
Elena Solfaroli Camillocci,
Marco Toppi,
Giacomo Traini,
Cecilia Voena,
Giuseppe Battistoni
Abstract:
Charged particle beams are used in Particle Therapy (PT) to treat oncological patients due to their selective dose deposition in tissues and to their high biological effect in killing cancer cells with respect to photons and electrons used in conventional radiotherapy. Nowadays, protons and carbon ions are used in PT clinical routine but, recently, the interest on the potential application of heli…
▽ More
Charged particle beams are used in Particle Therapy (PT) to treat oncological patients due to their selective dose deposition in tissues and to their high biological effect in killing cancer cells with respect to photons and electrons used in conventional radiotherapy. Nowadays, protons and carbon ions are used in PT clinical routine but, recently, the interest on the potential application of helium and oxygen beams is growing due to their reduced multiple scattering inside the body and increased linear energy transfer, relative biological effectiveness and oxygen enhancement ratio. The precision of PT demands for online dose monitoring techniques, crucial to improve the quality assurance of treatments. The beam range confined in the irradiated target can be monitored thanks to the neutral or charged secondary radiation emitted by the interactions of hadron beams with matter. Prompt photons are produced by nuclear de-excitation processes and, at present, different dose monitoring and beam range verification techniques based on the prompt γ detection have been proposed. It is hence of importance to perform the γ yield measurement in therapeutical-like conditions. In this paper we report the yields of prompt photons produced by the interaction of helium, carbon and oxygen ion beams with a PMMA target. The measurements were performed at the Heidelberg Ion-beam Therapy center (HIT) with beams of different energies. A LYSO scintillator has been used as photon detector. The obtained γ yields for $^{12}$C ion beams are compared with results from literature, while no other results from $^{4}$He and $^{16}$O beams have been published yet. A discussion on the expected resolution of a slit camera detector is presented, demonstrating the feasibility of a prompt-γ based monitoring technique for PT treatments using helium, carbon and oxygen ion beams.
△ Less
Submitted 19 July, 2016; v1 submitted 26 May, 2016;
originally announced May 2016.
-
Polycrystalline para-terphenyl scintillator adopted in a $β^-$ detecting probe for radio-guided surgery
Authors:
Elena Solfaroli Camillocci,
Fabio Bellini,
Valerio Bocci,
Francesco Collamati,
Erika De Lucia,
Riccardo Faccini,
Michela Marafini,
Ilaria Mattei,
Silvio Morganti,
Riccardo Paramatti,
Vincenzo Patera,
Davide Pinci,
Luigi Recchia,
Andrea Russomando,
Alessio Sarti,
Adalberto Sciubba,
Martina Senzacqua,
Cecilia Voena
Abstract:
A radio-guided surgery technique exploiting $β^-$ emitters is under development. It aims at a higher target-to-background activity ratio implying both a smaller radiopharmaceutical activity and the possibility of extending the technique to cases with a large uptake of surrounding healthy organs. Such technique requires a dedicated intraoperative probe detecting $β^-$ radiation. A first prototype h…
▽ More
A radio-guided surgery technique exploiting $β^-$ emitters is under development. It aims at a higher target-to-background activity ratio implying both a smaller radiopharmaceutical activity and the possibility of extending the technique to cases with a large uptake of surrounding healthy organs. Such technique requires a dedicated intraoperative probe detecting $β^-$ radiation. A first prototype has been developed relying on the low density and high light yield of the diphenylbutadiene doped para-therphenyl organic scintillator. The scintillation light produced in a cylindrical crystal, 5 mm in diameter and 3 mm in height, is guided to a photo-multiplier tube by optical fibres. The custom readout electronics is designed to optimize its usage in terms of feedback to the surgeon, portability and remote monitoring of the signal. Tests show that with a radiotracer activity comparable to those administered for diagnostic purposes the developed probe can detect a 0.1 ml cancerous residual of meningioma in a few seconds.
△ Less
Submitted 9 November, 2015;
originally announced November 2015.
-
An Intraoperative $β^-$ Detecting Probe For Radio-Guided Surgery in Tumour Resection
Authors:
Andrea Russomando,
Fabio Bellini,
Valerio Bocci,
Giacomo Chiodi,
Francesco Collamati,
Erika De Lucia,
Raffaella Donnarumma,
Riccardo Faccini,
Carlo Mancini Terracciano,
Michela Marafini,
Riccardo Paramatti,
Vincenzo Patera,
%Davide Pinci,
Luigi Recchia,
Alessio Sarti,
Adalberto Sciubba,
Elena Solfaroli Camillocci,
Cecilia Voena,
Silvio Morganti
Abstract:
The development of the $β^-$ based radio-guided surgery aims to extend the technique to those tumours where surgery is the only possible treatment and the assessment of the resection would most profit from the low background around the lesion, as for brain tumours. Feasibility studies on meningioma, glioma, and neuroendocrine tumors already estimated the potentiality of this new treatment. To vali…
▽ More
The development of the $β^-$ based radio-guided surgery aims to extend the technique to those tumours where surgery is the only possible treatment and the assessment of the resection would most profit from the low background around the lesion, as for brain tumours. Feasibility studies on meningioma, glioma, and neuroendocrine tumors already estimated the potentiality of this new treatment. To validate the technique, prototypes of the intraoperative probe required by the technique to detect $β^-$ radiation have been developed. This paper discusses the design details of the device and the tests performed in laboratory. In such tests particular care has to be taken to reproduce the surgical field conditions. The innovative technique to produce specific phantoms and the dedicated testing protocols is described in detail.
△ Less
Submitted 6 November, 2015;
originally announced November 2015.
-
Towards a Radio-guided Surgery with $β^{-}$ Decays: Uptake of a somatostatin analogue (DOTATOC) in Meningioma and High Grade Glioma
Authors:
Francesco Collamati,
Alessandra Pepe,
Fabio Bellini,
Valerio Bocci,
Marta Cremonesi,
Erika De Lucia,
Mahila Ferrari,
Paola M. Frallicciardi,
Chiara M. Grana,
Michela Marafini,
Ilaria Mattei,
Silvio Morganti,
Vincenzo Patera,
Luca Piersanti,
Luigi Recchia,
Andrea Russomando,
Alessio Sarti,
Adalberto Sciubba,
Martina Senzacqua,
Elena Solfaroli Camillocci,
Cecilia Voena,
Riccardo Faccini
Abstract:
A novel radio guided surgery (RGS) technique for cerebral tumors using $β^{-}$ radiation is being developed. Checking the availability of a radio-tracer that can deliver a $β^{-}$ emitter to the tumor is a fundamental step in the deployment of such technique. This paper reports a study of the uptake of 90Y labeled (DOTATOC) in the meningioma and the high grade glioma (HGG) and a feasibility study…
▽ More
A novel radio guided surgery (RGS) technique for cerebral tumors using $β^{-}$ radiation is being developed. Checking the availability of a radio-tracer that can deliver a $β^{-}$ emitter to the tumor is a fundamental step in the deployment of such technique. This paper reports a study of the uptake of 90Y labeled (DOTATOC) in the meningioma and the high grade glioma (HGG) and a feasibility study of the RGS technique in these cases.
△ Less
Submitted 23 December, 2014;
originally announced December 2014.
-
A novel radioguided surgery technique exploiting $β^{-}$ decays
Authors:
E. Solfaroli Camillocci,
G. Baroni,
F. Bellini,
V. Bocci,
F. Collamati,
M. Cremonesi,
E. De Lucia,
P. Ferroli,
S. Fiore,
C. M. Grana,
M. Marafini,
I. Mattei,
S. Morganti,
G. Paganelli,
V. Patera,
L. Piersanti,
L. Recchia,
A. Russomando,
M. Schiariti,
A. Sarti,
A. Sciubba,
C. Voena,
R. Faccini
Abstract:
The background induced by the high penetration power of the gamma radiation is the main limiting factor of the current Radio-guided surgery (RGS). To partially mitigate it, a RGS with beta+ emitting radio-tracers has been suggested in literature.
Here we propose the use of beta- emitting radio-tracers and beta- probes and discuss the advantage of this method with respect to the previously explor…
▽ More
The background induced by the high penetration power of the gamma radiation is the main limiting factor of the current Radio-guided surgery (RGS). To partially mitigate it, a RGS with beta+ emitting radio-tracers has been suggested in literature.
Here we propose the use of beta- emitting radio-tracers and beta- probes and discuss the advantage of this method with respect to the previously explored ones: the electron low penetration power allows for simple and versatile probes and could extend RGS to tumours for which background originating from nearby healthy tissue makes gamma probes less effective. We developed a beta- probe prototype and studied its performances on phantoms. By means of a detailed simulation we have also extrapolated the results to estimate the performances in a realistic case of meningioma, pathology which is going to be our first in-vivo test case. A good sensitivity to residuals down to 0.1ml can be reached within 1s with an administered activity smaller than those for PET-scans thus making the radiation exposure to medical personnel negligible.
△ Less
Submitted 10 February, 2014;
originally announced February 2014.
-
Extended calibration range for prompt photon emission in ion beam irradiation
Authors:
F. Bellini,
T. T. Boehlen,
M. P. W. Chin,
F. Collamati,
E. De Lucia,
R. Faccini,
A. Ferrari,
L. Lanza,
C. Mancini-Terraciano,
M. Marafini,
I. Mattei,
S. Morganti,
P. G. Ortega,
V. Patera,
L. Piersanti,
A. Russomando,
P. R. Sala,
A. Sarti,
A. Sciubba,
E. Solfaroli Camillocci,
C. Voena
Abstract:
Monitoring the dose delivered during proton and carbon ion therapy is still a matter of research. Among the possible solutions, several exploit the measurement of the single photon emission from nuclear decays induced by the irradiation. To fully characterize such emission the detectors need development, since the energy spectrum spans the range above the MeV that is not traditionally used in medi…
▽ More
Monitoring the dose delivered during proton and carbon ion therapy is still a matter of research. Among the possible solutions, several exploit the measurement of the single photon emission from nuclear decays induced by the irradiation. To fully characterize such emission the detectors need development, since the energy spectrum spans the range above the MeV that is not traditionally used in medical applications. On the other hand, a deeper understanding of the reactions involving gamma production is needed in order to improve the physic models of Monte Carlo codes, relevant for an accurate prediction of the prompt-gamma energy spectrum.This paper describes a calibration technique tailored for the range of energy of interest and reanalyzes the data of the interaction of a 80MeV/u fully stripped carbon ion beam with a Poly-methyl methacrylate target. By adopting the FLUKA simulation with the appropriate calibration and resolution a significant improvement in the agreement between data and simulation is reported.
△ Less
Submitted 22 July, 2013;
originally announced July 2013.
-
Properties of para-terphenyl as detector for alpha, beta and gamma radiation
Authors:
M. Angelone,
G. Battistoni,
F. Bellini,
V. Bocci,
F. Collamati,
E. De Lucia,
R. Faccini,
F. Ferroni,
S. Fiore,
M. Marafini,
D. Materazzo,
I. Mattei,
S. Morganti,
V. Patera,
L. Piersanti,
M. Pillon,
L. Recchia,
A. Russomando,
A. Sarti,
A. Sciubba,
E. Solfaroli Camillocci,
C. Voena
Abstract:
Organic scintillators are often chosen as radiation detectors for their fast decay time and their low Z, while inorganic ones are used when high light ields are required. In this paper we show that a para-terphenyl based detector has a blend of properties of the two categories that can be optimal for energy and position measurements of low energy charged particles. On 0.1% diphenylbutadiene doped…
▽ More
Organic scintillators are often chosen as radiation detectors for their fast decay time and their low Z, while inorganic ones are used when high light ields are required. In this paper we show that a para-terphenyl based detector has a blend of properties of the two categories that can be optimal for energy and position measurements of low energy charged particles. On 0.1% diphenylbutadiene doped para-terphenyl samples we measure a light yield 3.5+-0.2 times larger than a typical organic scintillator (EJ-200), and a rejection power for 660 keV photons, with respect to electrons of the same energy, ranging between 3-11%, depending on the signal threshold. We also measure a light attenuation length = 4.73+-0.06 mm and we demonstrate that, with the measurements performed in this paper, a simulation based on FLUKA can properly reproduce the measured spectra.
△ Less
Submitted 2 May, 2013;
originally announced May 2013.
-
Expected Performance of the ATLAS Experiment - Detector, Trigger and Physics
Authors:
The ATLAS Collaboration,
G. Aad,
E. Abat,
B. Abbott,
J. Abdallah,
A. A. Abdelalim,
A. Abdesselam,
O. Abdinov,
B. Abi,
M. Abolins,
H. Abramowicz,
B. S. Acharya,
D. L. Adams,
T. N. Addy,
C. Adorisio,
P. Adragna,
T. Adye,
J. A. Aguilar-Saavedra,
M. Aharrouche,
S. P. Ahlen,
F. Ahles,
A. Ahmad,
H. Ahmed,
G. Aielli,
T. Akdogan
, et al. (2587 additional authors not shown)
Abstract:
A detailed study is presented of the expected performance of the ATLAS detector. The reconstruction of tracks, leptons, photons, missing energy and jets is investigated, together with the performance of b-tagging and the trigger. The physics potential for a variety of interesting physics processes, within the Standard Model and beyond, is examined. The study comprises a series of notes based on…
▽ More
A detailed study is presented of the expected performance of the ATLAS detector. The reconstruction of tracks, leptons, photons, missing energy and jets is investigated, together with the performance of b-tagging and the trigger. The physics potential for a variety of interesting physics processes, within the Standard Model and beyond, is examined. The study comprises a series of notes based on simulations of the detector and physics processes, with particular emphasis given to the data expected from the first years of operation of the LHC at CERN.
△ Less
Submitted 14 August, 2009; v1 submitted 28 December, 2008;
originally announced January 2009.
